Fermín Goytisolo
Corporate Officer/Principal chez PANGAEA ONCOLOGY, S.A.
Profil
Fermín Goytisolo is currently the Director of Business Development & Licensing at Pangaea Oncology SA. Prior to this, he worked as a Biotechnology Manager at Najeti Capital SA, a Partner at Metas Biotech SL, and a Licensing Manager at Esteve Pharmaceuticals S.A.
Postes actifs de Fermín Goytisolo
| Sociétés | Poste | Début |
|---|---|---|
| PANGAEA ONCOLOGY, S.A. | Corporate Officer/Principal | - |
Anciens postes connus de Fermín Goytisolo
| Sociétés | Poste | Fin |
|---|---|---|
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - |
Najeti Capital SA
 Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Corporate Officer/Principal | - |
| Metas Biotech SL | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PANGAEA ONCOLOGY, S.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Najeti Capital SA
Najeti Capital SA Investment ManagersFinance Najeti Capital SA, formerly Najeti Capital SCR SA, invests in technology-driven, expansion projects with proprietary technologies across Europe with a special focus on Spain. It focuses on the sectors of biotechnology, telecommunications, media & technology (TMT) and services. The investment size ranges from €4 million to €8 million. It provides financing for growth or expansion capital requirements. It prefers to co-invest with other investors. | Finance |
| Metas Biotech SL | |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
